News - IMSDA

WHO Adds GLP-1 Drugs and New Cancer Treatments to Essential Medicines List in 2025 Update

Post published:May 18, 2026
Post category:Knowledge

The World Health Organization (WHO) has updated its Essential Medicines List (EML) in September 2025, adding several landmark drugs including GLP-1 receptor agonists for diabetes and obesity, new cancer treatments,…

Indian Pharma Exports Surge 18% in Q1 FY2026-27: US ANDA Approvals & Africa Demand Drive Growth

Post published:May 18, 2026
Post category:News

India's pharmaceutical export sector has recorded an impressive 18% growth in the first quarter of fiscal year 2026-27 (April–June 2026), driven by a surge in US ANDA (Abbreviated New Drug…

How Indian Generic Medicines Meet Global Quality Standards: WHO-GMP, USFDA & CDSCO Explained

Post published:May 16, 2026
Post category:Knowledge

Indian generic medicines supply over 20% of the global demand for pharmaceutical products by volume, yet many buyers and patients remain uncertain about how their quality is regulated. This article…

Indian Generic Pharma Exports Surge 14% in Q1 2026 as New PLI Scheme Targets 25 Additional API Molecules

Post published:May 16, 2026
Post category:News

The Indian pharmaceutical export sector has registered a robust 14% year-on-year growth in the first quarter of calendar 2026, reaching USD 8.4 billion, according to the latest data released by…